Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the endocrine system (HP:0000818)help
Parent Node:
expand
Abnormal circulating androgen level (HP:0030347)help
Parent Node:
expand
Puberty and gonadal disorders (HP:0008373)help
..Starting node
..expand
Abnormal circulating testosterone concentration (HP:0030087)help
Term ID: 30087
Name: Abnormal circulating testosterone concentration
Synonym: Abnormal serum testosterone level; Abnormal testosterone level
Definition: An anomalous concentration of testosterone in the blood.
Comments:
Reference: HP:0030087
Genes and Diseases:
 
       Child Nodes:
........expandIncreased serum testosterone level (HP:0030088) help
........expandDecreased serum testosterone level (HP:0040171) help
................... HP:0008230 Decreased testosterone in males

 Sister Nodes: 
..expandAbnormal circulating estrogen level (HP:0025132) help
..expandAbnormal circulating progesterone level (HP:0031212) help
..expandAbsence of pubertal development (HP:0008197) help
..expandAbsence of secondary sex characteristics (HP:0008187) help
..expandAdrenogenital syndrome (HP:0000840) help
..expandAndrogen insufficiency (HP:0008226) help
..expandDelayed puberty (HP:0000823) help
..expandEarly onset of sexual maturation (HP:0100000) help
..expandHypogonadism (HP:0000135) help
..expandIrregular menstruation (HP:0000858) help
..expandLeydig cell insensitivity to gonadotropin (HP:0002929) help
..expandPrimary gonadal insufficiency (HP:0008193) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0030087HP:0030087Abnormal circulating testosterone concentration0AKT1 CL E G H207391ORPHA:2495Meningioma54
HP:0030087HP:0030087Abnormal circulating testosterone concentration0ANOS1 CL E G H37306211OMIM:308700Hypogonadotropic hypogonadism 1 with or without anosmia65
HP:0030087HP:0030087Abnormal circulating testosterone concentration0AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndrome125
HP:0030087HP:0030087Abnormal circulating testosterone concentration0AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndrome125
HP:0030087HP:0030087Abnormal circulating testosterone concentration0B4GALNT1 CL E G H25834117ORPHA:101006Autosomal recessive spastic paraplegia type 2625
HP:0030087HP:0030087Abnormal circulating testosterone concentration0B4GALNT1 CL E G H25834117OMIM:609195Spastic paraplegia 26, autosomal recessive25
HP:0030087HP:0030087Abnormal circulating testosterone concentration0BAP1 CL E G H8314950ORPHA:2495Meningioma184
HP:0030087HP:0030087Abnormal circulating testosterone concentration0BMP6 CL E G H6541073ORPHA:465508Symptomatic form of hemochromatosis type 1
HP:0030087HP:0030087Abnormal circulating testosterone concentration0CHD7 CL E G H5563620626ORPHA:432Normosmic congenital hypogonadotropic hypogonadism515
HP:0030087HP:0030087Abnormal circulating testosterone concentration0CPE CL E G H13632303OMIM:619326BDV SYNDROME; BDVS
HP:0030087HP:0030087Abnormal circulating testosterone concentration0CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency2
HP:0030087HP:0030087Abnormal circulating testosterone concentration0CYP11B1 CL E G H15842591OMIM:202010Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency112
HP:0030087HP:0030087Abnormal circulating testosterone concentration0CYP11B1 CL E G H15842591ORPHA:90795Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency112
HP:0030087HP:0030087Abnormal circulating testosterone concentration0CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiency53
HP:0030087HP:0030087Abnormal circulating testosterone concentration0CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency53
HP:0030087HP:0030087Abnormal circulating testosterone concentration0DCAF17 CL E G H8006725784OMIM:241080Woodhouse-Sakati syndrome87
HP:0030087HP:0030087Abnormal circulating testosterone concentration0DCAF17 CL E G H8006725784ORPHA:3464Woodhouse-Sakati syndrome87
HP:0030087HP:0030087Abnormal circulating testosterone concentration0DHH CL E G H508462865ORPHA:16856346,XY gonadal dysgenesis-motor and sensory neuropathy syndrome21
HP:0030087HP:0030087Abnormal circulating testosterone concentration0DHX37 CL E G H5764717210OMIM:27325046, XY sex reversal 112
HP:0030087HP:0030087Abnormal circulating testosterone concentration0DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesis2
HP:0030087HP:0030087Abnormal circulating testosterone concentration0DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesis1
HP:0030087HP:0030087Abnormal circulating testosterone concentration0DMXL2 CL E G H233122938ORPHA:453533Polyendocrine-polyneuropathy syndrome3
HP:0030087HP:0030087Abnormal circulating testosterone concentration0DUSP6 CL E G H18483072ORPHA:432Normosmic congenital hypogonadotropic hypogonadism4
HP:0030087HP:0030087Abnormal circulating testosterone concentration0FGD1 CL E G H22453663OMIM:305400Aarskog-Scott syndrome62
HP:0030087HP:0030087Abnormal circulating testosterone concentration0FGF17 CL E G H88223673ORPHA:432Normosmic congenital hypogonadotropic hypogonadism3
HP:0030087HP:0030087Abnormal circulating testosterone concentration0FGF8 CL E G H22533686ORPHA:432Normosmic congenital hypogonadotropic hypogonadism17
HP:0030087HP:0030087Abnormal circulating testosterone concentration0FGFR1 CL E G H22603688ORPHA:432Normosmic congenital hypogonadotropic hypogonadism172
HP:0030087HP:0030087Abnormal circulating testosterone concentration0FSHB CL E G H24883964ORPHA:52901Isolated follicle stimulating hormone deficiency23
HP:0030087HP:0030087Abnormal circulating testosterone concentration0FSHR CL E G H24923969ORPHA:64739Ovarian hyperstimulation syndrome50
HP:0030087HP:0030087Abnormal circulating testosterone concentration0GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesis87
HP:0030087HP:0030087Abnormal circulating testosterone concentration0GCNA CL E G H9395315805OMIM:301077SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4
HP:0030087HP:0030087Abnormal circulating testosterone concentration0GNAS CL E G H27784392ORPHA:562McCune-Albright syndrome101
HP:0030087HP:0030087Abnormal circulating testosterone concentration0GNRH1 CL E G H27964419OMIM:614841Hypogonadotropic hypogonadism 12 with or without anosmia15
HP:0030087HP:0030087Abnormal circulating testosterone concentration0GNRH1 CL E G H27964419ORPHA:432Normosmic congenital hypogonadotropic hypogonadism15
HP:0030087HP:0030087Abnormal circulating testosterone concentration0GNRHR CL E G H27984421ORPHA:432Normosmic congenital hypogonadotropic hypogonadism92
HP:0030087HP:0030087Abnormal circulating testosterone concentration0HFE CL E G H30774886ORPHA:465508Symptomatic form of hemochromatosis type 138
HP:0030087HP:0030087Abnormal circulating testosterone concentration0HS6ST1 CL E G H93945201ORPHA:432Normosmic congenital hypogonadotropic hypogonadism8
HP:0030087HP:0030087Abnormal circulating testosterone concentration0HSD3B2 CL E G H32845218ORPHA:90791Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency34
HP:0030087HP:0030087Abnormal circulating testosterone concentration0INSR CL E G H36436091ORPHA:769Rabson-Mendenhall syndrome229
HP:0030087HP:0030087Abnormal circulating testosterone concentration0KISS1 CL E G H38146341ORPHA:432Normosmic congenital hypogonadotropic hypogonadism3
HP:0030087HP:0030087Abnormal circulating testosterone concentration0KISS1R CL E G H846344510ORPHA:432Normosmic congenital hypogonadotropic hypogonadism14
HP:0030087HP:0030087Abnormal circulating testosterone concentration0LEP CL E G H39526553ORPHA:66628Obesity due to congenital leptin deficiency47
HP:0030087HP:0030087Abnormal circulating testosterone concentration0LEPR CL E G H39536554ORPHA:179494Obesity due to leptin receptor gene deficiency46
HP:0030087HP:0030087Abnormal circulating testosterone concentration0LGR4 CL E G H5536613299OMIM:619613DELAYED PUBERTY, SELF-LIMITED; DPSL1
HP:0030087HP:0030087Abnormal circulating testosterone concentration0LHB CL E G H39726584OMIM:228300Hypogonadotropic hypogonadism 23 without anosmia9
HP:0030087HP:0030087Abnormal circulating testosterone concentration0MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesis13
HP:0030087HP:0030087Abnormal circulating testosterone concentration0NDNF CL E G H7962526256OMIM:618841HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA; HH25
HP:0030087HP:0030087Abnormal circulating testosterone concentration0NF2 CL E G H47717773ORPHA:2495Meningioma220
HP:0030087HP:0030087Abnormal circulating testosterone concentration0NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesis48
HP:0030087HP:0030087Abnormal circulating testosterone concentration0NR2F2 CL E G H70267976OMIM:61890146,XX SEX REVERSAL 5; SRXX513
HP:0030087HP:0030087Abnormal circulating testosterone concentration0NR3C1 CL E G H29087978ORPHA:786Generalized glucocorticoid resistance syndromeHP:0040282 - Frequent79
HP:0030087HP:0030087Abnormal circulating testosterone concentration0NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesis38
HP:0030087HP:0030087Abnormal circulating testosterone concentration0NSMF CL E G H2601229843ORPHA:432Normosmic congenital hypogonadotropic hypogonadism6
HP:0030087HP:0030087Abnormal circulating testosterone concentration0PDGFB CL E G H51558800ORPHA:2495Meningioma9
HP:0030087HP:0030087Abnormal circulating testosterone concentration0PIK3CA CL E G H52908975ORPHA:2495Meningioma162
HP:0030087HP:0030087Abnormal circulating testosterone concentration0POLA1 CL E G H54229173ORPHA:163976X-linked intellectual disability, Van Esch type2
HP:0030087HP:0030087Abnormal circulating testosterone concentration0POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndrome138
HP:0030087HP:0030087Abnormal circulating testosterone concentration0POLR3A CL E G H1112830074OMIM:264090Wiedemann-Rautenstrauch syndrome138
HP:0030087HP:0030087Abnormal circulating testosterone concentration0PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1134
HP:0030087HP:0030087Abnormal circulating testosterone concentration0PROK2 CL E G H6067518455ORPHA:432Normosmic congenital hypogonadotropic hypogonadism9
HP:0030087HP:0030087Abnormal circulating testosterone concentration0PROKR2 CL E G H12867415836ORPHA:432Normosmic congenital hypogonadotropic hypogonadism34
HP:0030087HP:0030087Abnormal circulating testosterone concentration0RBM28 CL E G H5513121863ORPHA:157954ANE syndrome1
HP:0030087HP:0030087Abnormal circulating testosterone concentration0SEMA3A CL E G H1037110723OMIM:614897Hypogonadotropic hypogonadism 16 with or without anosmia14
HP:0030087HP:0030087Abnormal circulating testosterone concentration0SLC39A4 CL E G H5563017129OMIM:201100Acrodermatitis enteropathica, Zinc-Deficiency type55
HP:0030087HP:0030087Abnormal circulating testosterone concentration0SMARCB1 CL E G H659811103ORPHA:2495Meningioma87
HP:0030087HP:0030087Abnormal circulating testosterone concentration0SMARCE1 CL E G H660511109ORPHA:2495Meningioma47
HP:0030087HP:0030087Abnormal circulating testosterone concentration0SMO CL E G H660811119ORPHA:2495Meningioma22
HP:0030087HP:0030087Abnormal circulating testosterone concentration0SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesis109
HP:0030087HP:0030087Abnormal circulating testosterone concentration0SPRY4 CL E G H8184815533ORPHA:432Normosmic congenital hypogonadotropic hypogonadism5
HP:0030087HP:0030087Abnormal circulating testosterone concentration0SRY CL E G H673611311ORPHA:177245,X/46,XY mixed gonadal dysgenesis23
HP:0030087HP:0030087Abnormal circulating testosterone concentration0SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesis23
HP:0030087HP:0030087Abnormal circulating testosterone concentration0SUFU CL E G H5168416466ORPHA:2495Meningioma124
HP:0030087HP:0030087Abnormal circulating testosterone concentration0TAC3 CL E G H686611521ORPHA:432Normosmic congenital hypogonadotropic hypogonadism6
HP:0030087HP:0030087Abnormal circulating testosterone concentration0TACR3 CL E G H687011528ORPHA:432Normosmic congenital hypogonadotropic hypogonadism34
HP:0030087HP:0030087Abnormal circulating testosterone concentration0TERT CL E G H701511730ORPHA:2495Meningioma238
HP:0030087HP:0030087Abnormal circulating testosterone concentration0TRAF7 CL E G H8423120456ORPHA:2495Meningioma
HP:0030087HP:0030087Abnormal circulating testosterone concentration0VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesis2
HP:0030087HP:0030087Abnormal circulating testosterone concentration0WDR11 CL E G H5571713831ORPHA:432Normosmic congenital hypogonadotropic hypogonadism10
HP:0030087HP:0030087Abnormal circulating testosterone concentration0WNT4 CL E G H5436112783ORPHA:247768Müllerian aplasia and hyperandrogenism4
HP:0030087HP:0030087Abnormal circulating testosterone concentration0WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesis177
HP:0030087HP:0030087Abnormal circulating testosterone concentration0WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesis149
HP:0030087HP:0030087Abnormal circulating testosterone concentration0ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesis31
HP:0030087HP:0040171Decreased serum testosterone concentration1AKT1 CL E G H207391ORPHA:2495MeningiomaHP:0040282 - Frequent54
HP:0030087HP:0040171Decreased serum testosterone concentration1ANOS1 CL E G H37306211OMIM:308700Hypogonadotropic hypogonadism 1 with or without anosmia65
HP:0030087HP:0030088Increased serum testosterone level1AR CL E G H367644ORPHA:99429Complete androgen insensitivity syndromeHP:0040281 - Very frequent125
HP:0030087HP:0030088Increased serum testosterone level1AR CL E G H367644ORPHA:90797Partial androgen insensitivity syndromeHP:0040281 - Very frequent125
HP:0030087HP:0040171Decreased serum testosterone concentration1B4GALNT1 CL E G H25834117ORPHA:101006Autosomal recessive spastic paraplegia type 26HP:0040284 - Very rare25
HP:0030087HP:0040171Decreased serum testosterone concentration1B4GALNT1 CL E G H25834117OMIM:609195Spastic paraplegia 26, autosomal recessiveHP:0040283 - Occasional25
HP:0030087HP:0040171Decreased serum testosterone concentration1BAP1 CL E G H8314950ORPHA:2495MeningiomaHP:0040282 - Frequent184
HP:0030087HP:0040171Decreased serum testosterone concentration1BMP6 CL E G H6541073ORPHA:465508Symptomatic form of hemochromatosis type 1HP:0040283 - Occasional
HP:0030087HP:0040171Decreased serum testosterone concentration1CHD7 CL E G H5563620626ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent515
HP:0030087HP:0040171Decreased serum testosterone concentration1CPE CL E G H13632303OMIM:619326BDV SYNDROME; BDVS
HP:0030087HP:0040171Decreased serum testosterone concentration1CYB5A CL E G H15282570ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent2
HP:0030087HP:0030088Increased serum testosterone level1CYP11B1 CL E G H15842591OMIM:202010Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency112
HP:0030087HP:0030088Increased serum testosterone level1CYP11B1 CL E G H15842591ORPHA:90795Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiencyHP:0040283 - Occasional112
HP:0030087HP:0040171Decreased serum testosterone concentration1CYP17A1 CL E G H15862593ORPHA:9079646,XY disorder of sex development due to isolated 17,20-lyase deficiencyHP:0040281 - Very frequent53
HP:0030087HP:0040171Decreased serum testosterone concentration1CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040281 - Very frequent53
HP:0030087HP:0040171Decreased serum testosterone concentration1DCAF17 CL E G H8006725784ORPHA:3464Woodhouse-Sakati syndromeHP:0040281 - Very frequent87
HP:0030087HP:0040171Decreased serum testosterone concentration1DCAF17 CL E G H8006725784OMIM:241080Woodhouse-Sakati syndrome.87
HP:0030087HP:0040171Decreased serum testosterone concentration1DHH CL E G H508462865ORPHA:16856346,XY gonadal dysgenesis-motor and sensory neuropathy syndromeHP:0040281 - Very frequent21
HP:0030087HP:0040171Decreased serum testosterone concentration1DHX37 CL E G H5764717210OMIM:27325046, XY sex reversal 112
HP:0030087HP:0040171Decreased serum testosterone concentration1DHX37 CL E G H5764717210ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0030087HP:0040171Decreased serum testosterone concentration1DMRT3 CL E G H5852413909ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent1
HP:0030087HP:0040171Decreased serum testosterone concentration1DMXL2 CL E G H233122938ORPHA:453533Polyendocrine-polyneuropathy syndromeHP:0040282 - Frequent3
HP:0030087HP:0040171Decreased serum testosterone concentration1DUSP6 CL E G H18483072ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent4
HP:0030087HP:0040171Decreased serum testosterone concentration1FGD1 CL E G H22453663OMIM:305400Aarskog-Scott syndrome62
HP:0030087HP:0040171Decreased serum testosterone concentration1FGF17 CL E G H88223673ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent3
HP:0030087HP:0040171Decreased serum testosterone concentration1FGF8 CL E G H22533686ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent17
HP:0030087HP:0040171Decreased serum testosterone concentration1FGFR1 CL E G H22603688ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent172
HP:0030087HP:0040171Decreased serum testosterone concentration1FSHB CL E G H24883964ORPHA:52901Isolated follicle stimulating hormone deficiencyHP:0040281 - Very frequent23
HP:0030087HP:0030088Increased serum testosterone level1FSHR CL E G H24923969ORPHA:64739Ovarian hyperstimulation syndromeHP:0040281 - Very frequent50
HP:0030087HP:0040171Decreased serum testosterone concentration1GATA4 CL E G H26264173ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent87
HP:0030087HP:0040171Decreased serum testosterone concentration1GCNA CL E G H9395315805OMIM:301077SPERMATOGENIC FAILURE, X-LINKED, 4; SPGFX4
HP:0030087HP:0030088Increased serum testosterone level1GNAS CL E G H27784392ORPHA:562McCune-Albright syndromeHP:0040282 - Frequent101
HP:0030087HP:0040171Decreased serum testosterone concentration1GNRH1 CL E G H27964419OMIM:614841Hypogonadotropic hypogonadism 12 with or without anosmia.15
HP:0030087HP:0040171Decreased serum testosterone concentration1GNRH1 CL E G H27964419ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent15
HP:0030087HP:0040171Decreased serum testosterone concentration1GNRHR CL E G H27984421ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent92
HP:0030087HP:0040171Decreased serum testosterone concentration1HFE CL E G H30774886ORPHA:465508Symptomatic form of hemochromatosis type 1HP:0040283 - Occasional38
HP:0030087HP:0040171Decreased serum testosterone concentration1HS6ST1 CL E G H93945201ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent8
HP:0030087HP:0040171Decreased serum testosterone concentration1HSD3B2 CL E G H32845218ORPHA:90791Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiencyHP:0040282 - Frequent34
HP:0030087HP:0030088Increased serum testosterone level1HSD3B2 CL E G H32845218ORPHA:90791Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiencyHP:0040282 - Frequent34
HP:0030087HP:0030088Increased serum testosterone level1INSR CL E G H36436091ORPHA:769Rabson-Mendenhall syndromeHP:0040282 - Frequent229
HP:0030087HP:0040171Decreased serum testosterone concentration1KISS1 CL E G H38146341ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent3
HP:0030087HP:0040171Decreased serum testosterone concentration1KISS1R CL E G H846344510ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent14
HP:0030087HP:0040171Decreased serum testosterone concentration1LEP CL E G H39526553ORPHA:66628Obesity due to congenital leptin deficiencyHP:0040281 - Very frequent47
HP:0030087HP:0040171Decreased serum testosterone concentration1LEPR CL E G H39536554ORPHA:179494Obesity due to leptin receptor gene deficiencyHP:0040281 - Very frequent46
HP:0030087HP:0040171Decreased serum testosterone concentration1LGR4 CL E G H5536613299OMIM:619613DELAYED PUBERTY, SELF-LIMITED; DPSL1
HP:0030087HP:0040171Decreased serum testosterone concentration1LHB CL E G H39726584OMIM:228300Hypogonadotropic hypogonadism 23 without anosmia.9
HP:0030087HP:0040171Decreased serum testosterone concentration1MAP3K1 CL E G H42146848ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent13
HP:0030087HP:0040171Decreased serum testosterone concentration1NDNF CL E G H7962526256OMIM:618841HYPOGONADOTROPIC HYPOGONADISM 25 WITH ANOSMIA; HH25
HP:0030087HP:0040171Decreased serum testosterone concentration1NF2 CL E G H47717773ORPHA:2495MeningiomaHP:0040282 - Frequent220
HP:0030087HP:0040171Decreased serum testosterone concentration1NR0B1 CL E G H1907960ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent48
HP:0030087HP:0030088Increased serum testosterone level1NR2F2 CL E G H70267976OMIM:61890146,XX SEX REVERSAL 5; SRXX513
HP:0030087HP:0040171Decreased serum testosterone concentration1NR5A1 CL E G H25167983ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent38
HP:0030087HP:0040171Decreased serum testosterone concentration1NSMF CL E G H2601229843ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent6
HP:0030087HP:0040171Decreased serum testosterone concentration1PDGFB CL E G H51558800ORPHA:2495MeningiomaHP:0040282 - Frequent9
HP:0030087HP:0040171Decreased serum testosterone concentration1PIK3CA CL E G H52908975ORPHA:2495MeningiomaHP:0040282 - Frequent162
HP:0030087HP:0040171Decreased serum testosterone concentration1POLA1 CL E G H54229173ORPHA:163976X-linked intellectual disability, Van Esch typeHP:0040282 - Frequent2
HP:0030087HP:0030088Increased serum testosterone level1POLR3A CL E G H1112830074OMIM:264090Wiedemann-Rautenstrauch syndrome.138
HP:0030087HP:0030088Increased serum testosterone level1POLR3A CL E G H1112830074ORPHA:3455Wiedemann-Rautenstrauch syndromeHP:0040284 - Very rare138
HP:0030087HP:0030088Increased serum testosterone level1PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1134
HP:0030087HP:0040171Decreased serum testosterone concentration1PROK2 CL E G H6067518455ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent9
HP:0030087HP:0040171Decreased serum testosterone concentration1PROKR2 CL E G H12867415836ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent34
HP:0030087HP:0040171Decreased serum testosterone concentration1RBM28 CL E G H5513121863ORPHA:157954ANE syndromeHP:0040282 - Frequent1
HP:0030087HP:0040171Decreased serum testosterone concentration1SEMA3A CL E G H1037110723OMIM:614897Hypogonadotropic hypogonadism 16 with or without anosmia14
HP:0030087HP:0040171Decreased serum testosterone concentration1SLC39A4 CL E G H5563017129OMIM:201100Acrodermatitis enteropathica, Zinc-Deficiency type.55
HP:0030087HP:0040171Decreased serum testosterone concentration1SMARCB1 CL E G H659811103ORPHA:2495MeningiomaHP:0040282 - Frequent87
HP:0030087HP:0040171Decreased serum testosterone concentration1SMARCE1 CL E G H660511109ORPHA:2495MeningiomaHP:0040282 - Frequent47
HP:0030087HP:0040171Decreased serum testosterone concentration1SMO CL E G H660811119ORPHA:2495MeningiomaHP:0040282 - Frequent22
HP:0030087HP:0040171Decreased serum testosterone concentration1SOX9 CL E G H666211204ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent109
HP:0030087HP:0040171Decreased serum testosterone concentration1SPRY4 CL E G H8184815533ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent5
HP:0030087HP:0040171Decreased serum testosterone concentration1SRY CL E G H673611311ORPHA:177245,X/46,XY mixed gonadal dysgenesisHP:0040283 - Occasional23
HP:0030087HP:0040171Decreased serum testosterone concentration1SRY CL E G H673611311ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent23
HP:0030087HP:0040171Decreased serum testosterone concentration1SUFU CL E G H5168416466ORPHA:2495MeningiomaHP:0040282 - Frequent124
HP:0030087HP:0040171Decreased serum testosterone concentration1TAC3 CL E G H686611521ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent6
HP:0030087HP:0040171Decreased serum testosterone concentration1TACR3 CL E G H687011528ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent34
HP:0030087HP:0040171Decreased serum testosterone concentration1TERT CL E G H701511730ORPHA:2495MeningiomaHP:0040282 - Frequent238
HP:0030087HP:0040171Decreased serum testosterone concentration1TRAF7 CL E G H8423120456ORPHA:2495MeningiomaHP:0040282 - Frequent
HP:0030087HP:0040171Decreased serum testosterone concentration1VAMP7 CL E G H684511486ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent2
HP:0030087HP:0040171Decreased serum testosterone concentration1WDR11 CL E G H5571713831ORPHA:432Normosmic congenital hypogonadotropic hypogonadismHP:0040281 - Very frequent10
HP:0030087HP:0030088Increased serum testosterone level1WNT4 CL E G H5436112783ORPHA:247768Müllerian aplasia and hyperandrogenismHP:0040281 - Very frequent4
HP:0030087HP:0040171Decreased serum testosterone concentration1WT1 CL E G H749012796ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent177
HP:0030087HP:0040171Decreased serum testosterone concentration1WWOX CL E G H5174112799ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent149
HP:0030087HP:0040171Decreased serum testosterone concentration1ZFPM2 CL E G H2341416700ORPHA:25151046,XY partial gonadal dysgenesisHP:0040281 - Very frequent31


Genes (73) :AKT1 ANOS1 AR B4GALNT1 BAP1 BMP6 CHD7 CPE CYB5A CYP11B1 CYP17A1 DCAF17 DHH DHX37 DMRT3 DMXL2 DUSP6 FGD1 FGF17 FGF8 FGFR1 FSHB FSHR GATA4 GCNA GNAS GNRH1 GNRHR HFE HS6ST1 HSD3B2 INSR KISS1 KISS1R LEP LEPR LGR4 LHB MAP3K1 NDNF NF2 NR0B1 NR2F2 NR3C1 NR5A1 NSMF PDGFB PIK3CA POLA1 POLR3A PRKAR1A PROK2 PROKR2 RBM28 SEMA3A SLC39A4 SMARCB1 SMARCE1 SMO SOX9 SPRY4 SRY SUFU TAC3 TACR3 TERT TRAF7 VAMP7 WDR11 WNT4 WT1 WWOX ZFPM2

Diseases (43) :ORPHA:2495 OMIM:308700 ORPHA:99429 ORPHA:90797 ORPHA:101006 OMIM:609195 ORPHA:465508 ORPHA:432 OMIM:619326 ORPHA:90796 OMIM:202010 ORPHA:90795 ORPHA:90793 OMIM:241080 ORPHA:3464 ORPHA:168563 OMIM:273250 ORPHA:251510 ORPHA:453533 OMIM:305400 ORPHA:52901 ORPHA:64739 OMIM:301077 ORPHA:562 OMIM:614841 ORPHA:90791 ORPHA:769 ORPHA:66628 ORPHA:179494 OMIM:619613 OMIM:228300 OMIM:618841 OMIM:618901 ORPHA:786 ORPHA:163976 ORPHA:3455 OMIM:264090 OMIM:610489 ORPHA:157954 OMIM:614897 OMIM:201100 ORPHA:1772 ORPHA:247768
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.